0 results for ''Frommer Lawrence''
Panel upholds $17M attorney fee award; cites bad-faith patent litigation by drug companies
A three-judge panel of the U.S. Court of Appeals for the Federal Circuit on Monday upheld an attorney fee award of nearly $17 million because of baseless filings and bad faith patent litigation by two generic drug companies, Mylan Laboratories and Alphapharm Pty. Ltd.Papyrus Technology Corp. v. New York Stock Exchange Inc.
Attorney's Disqualification Not Imputed to Firm; His Previous Involvement in Action Was MinisculeCorporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now